Patent Assignment
Reel/Frame 014546/0355
Assignment of Assignor's Interest
Recorded: 2003-10-01
Pages: 4
Assignor
AVENTIS PHARMA S.A.
Executed: 2003-08-01
Assignee
JONES PHARMA INCORPORATED
510 CUMBERLAND STREET, SUITE 200, BRISTOL, VIRGINIA, 24201
Covered Property
(1)
Pharmaceutical Compositions Based on Dalfopristine and on Quinupristine, and Preparation Thereof
Patent:
6,187,746 →
Application:
09/210,938 →
Related Assignments
(5)
Other recorded transfers of the patent in this record — the chain of ownership.
Merger and Change of Name
Mar 6, 2007
From: JONES PHARMA INCORPORATED
To: KING PHARMACEUTICALS RESEARCH AND DEVELOPMENT, INC
Reel/Frame 018961/0829 →
Security Agreement
Dec 30, 2008
From: KING PHARMACEUTICALS RESEARCH & DEVELOPMENT, INC.
To: CREDIT SUISSE, AS AGENT
Reel/Frame 022034/0870 →
Release of Security Interest
May 11, 2010
From: KING PHARMACEUTICALS RESEARCH AND DEVELOPMENT, INC.
To: CREDIT SUISSE AG
Reel/Frame 024369/0022 →
Security Agreement
May 13, 2010
From: KING PHARMACEUTICALS RESEARCH AND DEVELOPMENT, INC.
To: CREDIT SUISSE AG
Reel/Frame 025703/0628 →
Release of Security Interest
Feb 3, 2011
From: CREDIT SUISSE AG
To: KING PHARMACEUTICALS RESEARCH AND DEVELOPMENT, INC.
Reel/Frame 025738/0132 →